Buy Retatrutide 20mg Australia
★★★★★4.8 · 12 reviewsResearch Use Only: For laboratory research purposes only. Not for human or animal consumption.
Description
Retatrutide (LY3437943) is a novel single-peptide triple receptor agonist developed by Eli Lilly, with balanced activity at the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). This multi-receptor mechanism combines GLP-1R- and GIPR-driven appetite suppression with GCGR-mediated increases in energy expenditure. In a Phase 2 NEJM-published trial (2023, n=338, 48 weeks), retatrutide at the highest dose produced mean body weight reduction of approximately 24% in adults with obesity. Phase 1b studies in type 2 diabetes showed dose-dependent HbA1c reductions up to 1.6% and pharmacokinetics supporting once-weekly dosing (t½ ~6 days). This 20mg research vial supports laboratory investigation of incretin receptor pharmacology, multi-agonist metabolic signalling, and adipose tissue biology. CAS: 2381272-06-4. For research use only. Not for human consumption.
Research Guide Available , read the science, mechanism, and research data for this compound.
Frequently Asked Questions
Research Use Only: This product is for laboratory research purposes only. Not for human consumption. All compounds are sourced from suppliers with a verified Certificate of Analysis (COA).
Customer Reviews
Well packed, arrived cold.
Happy with the purchase
Packaging was excellent.
Fast shipping, discreet. No complaints.
Trustworthy company
Would order again.
Quick delivery, very happy with customer support
No dramas at all